ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,327.825
0.10%
Brent Oil
85.24
0.15%
Bitcoin
63,457.23
1.26%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Roche Holdings Ltd AG (QX) (RHHBY)

  7. Roche Holdings Ltd AG (QX) (RHHBY) News

Roche (QX) (RHHBY)

Roche Holdings Ltd AG (QX)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:RHHBY
DateTimeSourceHeadlineSymbolCompany
16/01/202406:49Dow Jones NewsRoche's Cancer Injection Tecentriq SC Gets European Commission ApprovalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
10/01/202413:45InvestorsHub NewsWireGLP-1: Beyond Diabetes, a Blockbuster Horizon BeckonsUSOTC:RHHBYRoche Holdings Ltd AG (QX)
29/12/202322:07Dow Jones NewsLumiraDx Agrees to Sell Point-of-Care Tech Platform to RocheUSOTC:RHHBYRoche Holdings Ltd AG (QX)
19/12/202315:27Dow Jones NewsRoche's Xolair Granted FDA Priority ReviewUSOTC:RHHBYRoche Holdings Ltd AG (QX)
11/12/202315:31Dow Jones NewsPoseida Therapeutics Shares Climb on Positive Data for Blood Cancer TreatmentUSOTC:RHHBYRoche Holdings Ltd AG (QX)
08/12/202317:56Dow Jones NewsRoche Obtains Positive Data on Early-Stage Breast Cancer TreatmentUSOTC:RHHBYRoche Holdings Ltd AG (QX)
08/12/202317:38Dow Jones NewsRoche's Inavolisib Breast Cancer Drug Gets Positive ResultsUSOTC:RHHBYRoche Holdings Ltd AG (QX)
06/12/202310:14Dow Jones NewsMerck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage TrialsUSOTC:RHHBYRoche Holdings Ltd AG (QX)
05/12/202306:54Dow Jones NewsRoche's Inavolisib Breast Cancer Drug Shows Promise in Late-Stage StudyUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202315:12Dow Jones NewsTrending: Roche to Buy Carmot Therapeutics in Deal Worth Up to $3.1 BillionUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202311:34Dow Jones NewsRoche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments -- UpdateUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202310:55IH Market NewsAlaska Air Acquires Hawaiian Holdings, Spotify Cuts 1,500 Jobs, Uber’s S&P 500 Entry, and MoreUSOTC:RHHBYRoche Holdings Ltd AG (QX)
04/12/202306:47Dow Jones NewsRoche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 BillionUSOTC:RHHBYRoche Holdings Ltd AG (QX)
21/11/202316:06Dow Jones NewsRoche's Genentech, Nvidia Team Up to Accelerate Drug Discovery With AIUSOTC:RHHBYRoche Holdings Ltd AG (QX)
07/11/202322:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:RHHBYRoche Holdings Ltd AG (QX)
31/10/202306:26Dow Jones NewsRoche Says Late-Stage Muscular Dystrophy Trial Didn't Meet Main GoalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
27/10/202306:40Dow Jones NewsRoche Gets FDA Approval for Vabysmo as Retinal Vein Occlusion TreatmentUSOTC:RHHBYRoche Holdings Ltd AG (QX)
23/10/202320:41Dow Jones NewsTrending: Roche to Buy Telavant From Roivant and PfizerUSOTC:RHHBYRoche Holdings Ltd AG (QX)
23/10/202309:16Dow Jones NewsRoche to Buy Telavant From Roivant, Pfizer in Deal Worth Up to $7.25 Billion -- UpdateUSOTC:RHHBYRoche Holdings Ltd AG (QX)
23/10/202306:50Dow Jones NewsRoche to Buy Telavant From Roivant Sciences and Pfizer in $7.25 Billion DealUSOTC:RHHBYRoche Holdings Ltd AG (QX)
19/10/202310:55Dow Jones NewsRoche Shares Fall on Lower Sales Due to Currency HitUSOTC:RHHBYRoche Holdings Ltd AG (QX)
19/10/202306:48Dow Jones NewsRoche Backs Guidance After Sales FallUSOTC:RHHBYRoche Holdings Ltd AG (QX)
18/10/202307:14Dow Jones NewsRoche Lung Cancer Drug Reduced Risk of Recurrence, Death in Late-Stage TrialUSOTC:RHHBYRoche Holdings Ltd AG (QX)
18/10/202306:54Dow Jones NewsRoche's Elecsys IL-6 Test Approved for Diagnosis of Neonatal SepsisUSOTC:RHHBYRoche Holdings Ltd AG (QX)
29/09/202313:15Dow Jones NewsAbbVie: Phase 3 Venetoclax/Dexamethasone Study Falls Short in Multiple MyelomaUSOTC:RHHBYRoche Holdings Ltd AG (QX)
27/09/202312:59Dow Jones NewsIonis, Roche Set New Pact Targeting Alzheimer's, Huntington'sUSOTC:RHHBYRoche Holdings Ltd AG (QX)
20/09/202313:45InvestorsHub NewsWirePathways to Progress: How Orphan Drug Designation Sparks Biotech TransformationUSOTC:RHHBYRoche Holdings Ltd AG (QX)
06/09/202306:52Dow Jones NewsRoche's Blood Disorder Drug Crovalimab Takes Step Toward FDA ApprovalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
01/09/202307:04Dow Jones NewsRoche Lung Cancer Drug Shows Promise in Phase 3 TrialUSOTC:RHHBYRoche Holdings Ltd AG (QX)
29/08/202310:51Dow Jones NewsRoche's Tecentriq Intravenous Cancer Therapy Gets UK ApprovalUSOTC:RHHBYRoche Holdings Ltd AG (QX)
 Showing the most relevant articles for your search:USOTC:RHHBY

Your Recent History

LSE
GPM
Golden Prospect Precious...
LSE
BMN
Bushveld Minerals
LSE
BARC
Barclays
LSE
GGP
Greatland Gold
LSE
MATD
Petro Matad
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved